Klotho Neurosciences Inc (KLTO)

$0.27 0.00 (-0.77%)
Market Cap 19.94M
Revenue (ttm) 0.00
Net Income (ttm) -6.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 654,700
Avg Vol 739,016
Day's Range N/A - N/A
Shares Out 73.54M
Stochastic %K 17%
Beta 10.27
Analysts Strong Buy
Price Target N/A

Company Profile

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha,...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 931 6330
Address:
13576 Walnut Street, Suite A, Omaha, United States
RedDogSailor
RedDogSailor Jan. 30 at 4:33 PM
$KLTO I’m holding. I can wait for the inevitable boom.
2 · Reply
zack_instock
zack_instock Jan. 30 at 4:28 PM
$KLTO still any hopes or nothing?
0 · Reply
Boogerfloop19
Boogerfloop19 Jan. 29 at 6:57 PM
$KLTO yeh I’m next I have 14000 shares .67 average probably sell before r/s next month
1 · Reply
LoyalDragon
LoyalDragon Jan. 29 at 3:13 PM
$KLTO will it ever recover? Sold 6k shares today 😕 an awful day to sell but I just can’t take it anymore
0 · Reply
Stephan85
Stephan85 Jan. 27 at 2:39 PM
$NAK $KLTO $SOAR $HIND $HCTI Horrible….
0 · Reply
Beanie_Mojo
Beanie_Mojo Jan. 26 at 6:12 PM
$KLTO
0 · Reply
Dontbadick
Dontbadick Jan. 26 at 4:03 PM
$KLTO
0 · Reply
zack_instock
zack_instock Jan. 25 at 12:58 PM
$KLTO Let’s see your legend of being 0.1 and become 1 after reverse spilt 😮‍💨
0 · Reply
Prettyricky13
Prettyricky13 Jan. 23 at 12:23 AM
$KLTO only thing coming here is reverse split
0 · Reply
Topdog007
Topdog007 Jan. 22 at 8:30 PM
$KLTO HALT IT
0 · Reply
Latest News on KLTO
Klotho Neurosciences to Present at the Biotech Showcase 2026

Jan 8, 2026, 8:00 AM EST - 26 days ago

Klotho Neurosciences to Present at the Biotech Showcase 2026

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Nov 7, 2025, 10:03 AM EST - 3 months ago

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Oct 16, 2025, 8:00 AM EDT - 3 months ago

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Klotho Neurosciences Announces Expiration of Letter of Intent

Oct 7, 2025, 6:20 PM EDT - 4 months ago

Klotho Neurosciences Announces Expiration of Letter of Intent

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

Sep 30, 2025, 8:30 AM EDT - 4 months ago

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Sep 8, 2025, 8:00 AM EDT - 5 months ago

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Aug 18, 2025, 8:30 AM EDT - 6 months ago

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology

Aug 12, 2025, 6:00 AM EDT - 6 months ago

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 25, 2025, 9:05 PM EDT - 6 months ago

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 24, 2025, 1:30 PM EDT - 6 months ago

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Jul 22, 2025, 10:21 AM EDT - 7 months ago

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Jul 16, 2025, 6:00 AM EDT - 7 months ago

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")

Jul 10, 2025, 5:00 AM EDT - 7 months ago

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")

This Penny Stock Exploded 500% In June: What You Need To Know

Jun 30, 2025, 11:07 AM EDT - 7 months ago

This Penny Stock Exploded 500% In June: What You Need To Know

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

Jun 30, 2025, 2:00 AM EDT - 7 months ago

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

Jun 24, 2025, 5:00 AM EDT - 8 months ago

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

Jun 18, 2025, 7:00 AM EDT - 8 months ago

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT

Jun 16, 2025, 7:00 AM EDT - 8 months ago

KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT

Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?

Jun 10, 2025, 11:00 AM EDT - 8 months ago

Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?

KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")

Jun 9, 2025, 7:00 AM EDT - 8 months ago

KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Jan 8, 2025, 11:00 AM EST - 1 year ago

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein

Jun 26, 2024, 5:00 AM EDT - 1 year ago

ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein

RedDogSailor
RedDogSailor Jan. 30 at 4:33 PM
$KLTO I’m holding. I can wait for the inevitable boom.
2 · Reply
zack_instock
zack_instock Jan. 30 at 4:28 PM
$KLTO still any hopes or nothing?
0 · Reply
Boogerfloop19
Boogerfloop19 Jan. 29 at 6:57 PM
$KLTO yeh I’m next I have 14000 shares .67 average probably sell before r/s next month
1 · Reply
LoyalDragon
LoyalDragon Jan. 29 at 3:13 PM
$KLTO will it ever recover? Sold 6k shares today 😕 an awful day to sell but I just can’t take it anymore
0 · Reply
Stephan85
Stephan85 Jan. 27 at 2:39 PM
$NAK $KLTO $SOAR $HIND $HCTI Horrible….
0 · Reply
Beanie_Mojo
Beanie_Mojo Jan. 26 at 6:12 PM
$KLTO
0 · Reply
Dontbadick
Dontbadick Jan. 26 at 4:03 PM
$KLTO
0 · Reply
zack_instock
zack_instock Jan. 25 at 12:58 PM
$KLTO Let’s see your legend of being 0.1 and become 1 after reverse spilt 😮‍💨
0 · Reply
Prettyricky13
Prettyricky13 Jan. 23 at 12:23 AM
$KLTO only thing coming here is reverse split
0 · Reply
Topdog007
Topdog007 Jan. 22 at 8:30 PM
$KLTO HALT IT
0 · Reply
Topdog007
Topdog007 Jan. 22 at 8:30 PM
$KLTO LET'S GO
0 · Reply
Topdog007
Topdog007 Jan. 22 at 8:29 PM
$KLTO
0 · Reply
Beanie_Mojo
Beanie_Mojo Jan. 22 at 4:55 PM
$KLTO its on hold for r/s for the compliance meet otherwise delist by march 18.
0 · Reply
zack_instock
zack_instock Jan. 18 at 4:07 AM
$KLTO man, ready for 0.1-0.2 before reverse split?
1 · Reply
Beanie_Mojo
Beanie_Mojo Jan. 16 at 6:51 PM
$KLTO ❔
0 · Reply
zack_instock
zack_instock Jan. 16 at 3:31 PM
$KLTO $10？
0 · Reply
REXOM
REXOM Jan. 15 at 7:40 PM
$KLTO .60 next leg. Alzheimer stock. boom boom like $PTHL and $AUID
0 · Reply
REXOM
REXOM Jan. 15 at 6:33 PM
$KLTO .50 next leg. micro float. $AUID my call at 1.03 hit 2.49 $NUWE my call at 1.95 hit 2.85
0 · Reply
REXOM
REXOM Jan. 15 at 6:27 PM
$KLTO .50 next leg. small float. big cash. 0 debt. big news. new $CJMB and $AUID my call at 1.03 hit 2.49
0 · Reply
REXOM
REXOM Jan. 15 at 6:13 PM
$KLTO my call at 0.19 hit 3.91 last year. 0 debt. let's do it again
0 · Reply
Dontbadick
Dontbadick Jan. 15 at 2:57 PM
$KLTO Oh, look, another pumper and another red day.
0 · Reply
Dontbadick
Dontbadick Jan. 14 at 8:56 PM
$KLTO There is NO pipeline.
1 · Reply